Intratumoral Estrogens and Estrogen Receptors in Human Non–Small Cell Lung Carcinoma
Authors:
- 15 July 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (14) , 4417-4426
Abstract
Purpose: The possible involvement of gender-dependent factors has been suggested in human non-small cell lung carcinomas (NSCLC), but their precise roles remain largely unclear. Therefore, we examined intratumoral estradiol concentrations in NSCLC to examine local actions of estrogens in NSCLC. Experimental Design: Fifty-nine frozen specimens of NSCLC were available for liquid chromatography/electrospray tandem mass spectrometry to study intratumoral estradiol concentrations. In addition, A549 NSCLC cells stably expressing estrogen receptor (ER) α (A549 + ERα) or ERβ (A549 + ERβ) were used in vitro studies. Results: Forty-three (73%) of 59 NSCLC showed higher concentration of estradiol in carcinoma tissues than the corresponding nonneoplastic lung tissues from the same patient, and intratumoral estradiol concentrations were significantly (P = 0.0002 and 2.2-fold) higher than the corresponding nonneoplastic lungs. The intratumoral concentration of estradiol was positively correlated with aromatase expression, tumor size, and Ki-67 status in ERα- or ERβ-positive cases. In in vitro studies, estradiol significantly increased cell proliferation of A549 + ERα or A549 + ERβ, which was significantly suppressed by selective ER modulators, tamoxifen or raloxifene. Both A549 + ERα and A549 + ERβ cells expressed aromatase. The cell proliferation level in these cells was significantly increased under treatment with testosterone, and it was inhibited by addition of the aromatase inhibitor letrozole. Conclusions: These results suggest that estradiol is locally produced in NSCLC mainly by aromatase and plays an important role in the growth of ERα- or ERβ-positive NSCLC. Therefore, use of selective ER modulators and/or aromatase inhibitors may be clinically effective in NSCLC that are positive for both ER and aromatase.Keywords
This publication has 35 references indexed in Scilit:
- Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung CancerCancer Research, 2007
- Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factorEndocrine-Related Cancer, 2007
- 5α‐Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen productionInternational Journal of Cancer, 2006
- Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung CancerJournal of Clinical Oncology, 2006
- Aromatase Inhibitors in Human Lung Cancer TherapyCancer Research, 2005
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Progesterone Receptor in Non–Small Cell Lung Cancer—A Potent Prognostic Factor and Possible Target for Endocrine TherapyCancer Research, 2005
- Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cellsSteroids, 2005
- Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung CancersBiochemical and Biophysical Research Communications, 2001
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996